Childhood Cancer Model Atlas
The Childhood Cancer Model Atlas (CCMA), housed at Hudson Institute’s Centre for Cancer Research, leverages the world’s largest collection of paediatric cancer cell lines and AI-powered analytics to drive innovative research and clinical translation.
The CCMA includes more than 400 high-risk paediatric cancer cell lines. This unique and open-source repository was established through the collaboration of nearly 50 leading cancer research institutes, universities, and academic medical centres worldwide.
The CCMA provides a unique, open-source facility to cancer researchers globally, and is available to every paediatric oncologist and childhood cancer researcher. Using the CCMA, researchers can have potential treatments tested and analysed using cutting-edge AI techniques. By facilitating shared ‘big data’ the CCMA is accelerating the discovery of new therapies and biomarkers for childhood cancers.
A world leader in the field of paediatric cancer research, Hudson Institute’s Next Generation Precision Medicine program comprises a multidisciplinary team of researchers and clinicians working to improve survival rates and long-term health outcomes for children with cancer.
